📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: OmicEra

1.1 - Company Overview

OmicEra Logo

OmicEra

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of proteomics and artificial intelligence (AI) capabilities for medical diagnostics, leveraging high-end mass spectrometry-based proteomics to improve human health, with transparency, reproducible results, and open-source software development at its core.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to OmicEra

Causaly Logo

Causaly

HQ: United Kingdom Website
  • Description: Provider of a biomedical research discovery platform that finds and unlocks hidden evidence in biomedicine to accelerate drug discovery. Offers Causaly Cloud to find, analyze and connect evidence from biomedical documents, a hypothesis generation tool to identify mediators of target-disease effects, and advanced filtering by target class for a granular view of targets for specific diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Causaly company profile →
NextBio Logo

NextBio

HQ: United States Website
  • Description: Provider of an ontology-based software platform enabling life science researchers to search, discover, and share knowledge across public and proprietary data.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NextBio company profile →
Biognosys Logo

Biognosys

HQ: Switzerland Website
  • Description: Provider of integrated proteomics solutions and contract research services for pharma and biotech, including TrueDiscovery for deep, unbiased profiling across drug development, TrueTarget for drug target deconvolution and binding site mapping, TrueSignature custom panels for absolute protein quantification, Spectronaut mass spectrometry analysis software, and PQ500 kit for quantifying 500+ plasma proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biognosys company profile →
Kadrige Logo

Kadrige

HQ: France Website
  • Description: Provider of Software-as-a-Service (SaaS) e-detailing and collaborative solutions, offering project management, IT solutions implementation, technical integration, customization, consulting, and support services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kadrige company profile →
Dotmatics Logo

Dotmatics

HQ: United States Website
  • Description: Provider of an enterprise R&D scientific software platform connecting science, data, and decision-making, with applications including electronic laboratory notebook (Dotmatics ELN), Luma AI-native multimodal scientific intelligence, scientific search, small molecule drug discovery solution, and visualization & analytics to streamline research workflows and accelerate innovation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dotmatics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for OmicEra

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to OmicEra

2.2 - Growth funds investing in similar companies to OmicEra

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for OmicEra

4.2 - Public trading comparable groups for OmicEra

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to OmicEra

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About OmicEra

What does OmicEra do?

OmicEra is a provider of proteomics and artificial intelligence (AI) capabilities for medical diagnostics, leveraging high-end mass spectrometry-based proteomics to improve human health, with transparency, reproducible results, and open-source software development at its core.

Who are OmicEra's competitors?

OmicEra's competitors and similar companies include Causaly, NextBio, Biognosys, Kadrige, and Dotmatics.

Where is OmicEra headquartered?

OmicEra is headquartered in Germany.

How many employees does OmicEra have?

OmicEra has 1,000 employees 🔒.

When was OmicEra founded?

OmicEra was founded in 2010 🔒.

What sector and industry vertical is OmicEra in?

OmicEra is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for OmicEra

Who are the top strategic acquirers in OmicEra's sector and industry

Top strategic M&A buyers and acquirers in OmicEra's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for OmicEra?

Top strategic M&A buyers groups and sectors for OmicEra include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in OmicEra's sector and industry vertical

Which are the top PE firms investing in OmicEra's sector and industry vertical?

Top PE firms investing in OmicEra's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in OmicEra's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in OmicEra's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in OmicEra's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to OmicEra include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in OmicEra's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for OmicEra?

The key public trading comparables and valuation benchmarks for OmicEra include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for OmicEra for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for OmicEra with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in OmicEra's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for OmicEra with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in OmicEra's' sector and industry vertical?

Access recent funding rounds and capital raises in OmicEra's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for OmicEra